Definium Therapeutics Says Unprecedented Efficacy From Anxiety Study 'Raises the Bar'
Biotech ETF Index Surges 10% After Rebalance
Definium Shares Soar After Reporting Positive Phase 3 Results For Single-Dose Depression Treatment
Definium Therapeutics (DFTX) Stock Gains After Hours: Here's What's Driving The Move
How Trump's psychedelics executive order could unlock stalled cannabis reform